Rodger Novak Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rodger Novak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rodger Novak. Rodger Novak is Chief Executive Officer in CRISPR Therapeutics AG ($CRSP) and President in CRISPR Therapeutics AG ($CRSP).
Latest Insider Trading Transactions of Rodger Novak
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 50,000 | 721,500 | 140,315 | |
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 50,000 | 700,000 | 61,893 | |
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 125.00 | 50,000 | 6,250,000 | 648,007 | 698 K to 648 K (-7.16 %) |
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 50,000 | 721,500 | 698,007 | 648 K to 698 K (+7.72 %) |
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 125.00 | 50,000 | 6,250,000 | 648,007 | 698 K to 648 K (-7.16 %) |
| Dec 02 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 50,000 | 700,000 | 698,007 | 648 K to 698 K (+7.72 %) |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 2,762 | 39,856 | 190,315 | |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 22,238 | 320,894 | 193,077 | |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 100.00 | 2,762 | 276,200 | 648,007 | 650.8 K to 648 K (-0.42 %) |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 2,762 | 39,856 | 650,769 | 648 K to 650.8 K (+0.43 %) |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 100.00 | 22,238 | 2,223,800 | 648,007 | 670.2 K to 648 K (-3.32 %) |
| Oct 13 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 22,238 | 320,894 | 670,245 | 648 K to 670.2 K (+3.43 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 21,067 | 303,997 | 215,315 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 3,933 | 55,062 | 111,893 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 93.19 | 3,840 | 357,850 | 648,007 | 651.8 K to 648 K (-0.59 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 92.59 | 19,754 | 1,829,023 | 651,847 | 671.6 K to 651.8 K (-2.94 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 91.54 | 1,406 | 128,705 | 671,601 | 673 K to 671.6 K (-0.21 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 21,067 | 303,997 | 673,007 | 651.9 K to 673 K (+3.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 3,933 | 55,062 | 651,940 | 648 K to 651.9 K (+0.61 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 21,067 | 303,997 | 215,315 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 3,933 | 55,062 | 111,893 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 93.19 | 3,840 | 357,850 | 648,007 | 651.8 K to 648 K (-0.59 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 92.59 | 19,754 | 1,829,023 | 651,847 | 671.6 K to 651.8 K (-2.94 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 91.54 | 1,406 | 128,705 | 671,601 | 673 K to 671.6 K (-0.21 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 21,067 | 303,997 | 673,007 | 651.9 K to 673 K (+3.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 3,933 | 55,062 | 651,940 | 648 K to 651.9 K (+0.61 %) |
| Aug 21 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 25,000 | 350,000 | 115,826 | |
| Aug 21 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 100.00 | 25,000 | 2,500,000 | 648,007 | 673 K to 648 K (-3.71 %) |
| Aug 21 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 25,000 | 350,000 | 673,007 | 648 K to 673 K (+3.86 %) |
| Jul 09 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 19,414 | 271,796 | 140,826 | |
| Jul 09 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 1.81 | 5,586 | 10,111 | 0 | |
| Jul 09 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 90.00 | 25,000 | 2,250,000 | 648,007 | 673 K to 648 K (-3.71 %) |
| Jul 09 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 19,414 | 271,796 | 673,007 | 653.6 K to 673 K (+2.97 %) |
| Jul 09 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 1.81 | 5,586 | 10,111 | 653,593 | 648 K to 653.6 K (+0.86 %) |
| Jul 06 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 80.00 | 50,000 | 4,000,000 | 648,007 | 698 K to 648 K (-7.16 %) |
| Jun 25 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 75.00 | 50,000 | 3,750,000 | 698,007 | 748 K to 698 K (-6.68 %) |
| May 27 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 70.27 | 36,616 | 2,573,006 | 748,007 | 784.6 K to 748 K (-4.67 %) |
| May 27 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 70.01 | 13,384 | 937,014 | 784,623 | 798 K to 784.6 K (-1.68 %) |
| May 21 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 65.00 | 50,000 | 3,250,000 | 798,007 | 848 K to 798 K (-5.90 %) |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 33,618 | 485,108 | 236,382 | |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 70.00 | 33,618 | 2,353,260 | 0 | 33.6 K to 0 (-100.00 %) |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 33,618 | 485,108 | 33,618 | 0 to 33.6 K |
| Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 50.00 | 50,000 | 2,500,065 | 848,007 | 898 K to 848 K (-5.57 %) |
| Jun 12 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 45.00 | 50,000 | 2,250,000 | 898,007 | 948 K to 898 K (-5.27 %) |
| Feb 27 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 40.00 | 14,780 | 591,233 | 1,033,227 | 1 M to 1 M (-1.41 %) |
| Jan 10 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 35.01 | 82,690 | 2,894,977 | 1,048,007 | 1.1 M to 1 M (-7.31 %) |
| Jan 10 2019 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 35.09 | 17,310 | 607,408 | 1,130,697 | 1.1 M to 1.1 M (-1.51 %) |
| May 21 2018 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 39,760 | 556,640 | 160,240 | |
| May 21 2018 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 1.81 | 35,240 | 63,784 | 5,586 | |
| May 21 2018 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 60.00 | 75,000 | 4,500,000 | 1,148,007 | 1.2 M to 1.1 M (-6.13 %) |
| May 21 2018 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 39,760 | 556,640 | 1,223,007 | 1.2 M to 1.2 M (+3.36 %) |
| May 21 2018 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 1.81 | 35,240 | 63,784 | 1,183,247 | 1.1 M to 1.2 M (+3.07 %) |
| Sep 05 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 3,853 | 6,974 | 40,826 | |
| Sep 05 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 20.33 | 3,853 | 78,320 | 1,148,007 | 1.2 M to 1.1 M (-0.33 %) |
| Sep 05 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 3,853 | 6,974 | 1,151,860 | 1.1 M to 1.2 M (+0.34 %) |
| Sep 05 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 20.87 | 14,617 | 305,073 | 1,148,007 | 1.2 M to 1.1 M (-1.26 %) |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 5,722 | 10,357 | 44,679 | |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 17,692 | 32,023 | 50,401 | |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 20.31 | 58,103 | 1,179,950 | 1,162,624 | 1.2 M to 1.2 M (-4.76 %) |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 5,722 | 10,357 | 1,220,727 | 1.2 M to 1.2 M (+0.47 %) |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 20.06 | 17,692 | 354,919 | 1,215,005 | 1.2 M to 1.2 M (-1.44 %) |
| Aug 30 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 17,692 | 32,023 | 1,232,697 | 1.2 M to 1.2 M (+1.46 %) |
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 10,825 | 19,593 | 68,093 | |
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.37 | 10,825 | 166,388 | 1,215,005 | 1.2 M to 1.2 M (-0.88 %) |
| Jun 23 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 10,825 | 19,593 | 1,225,830 | 1.2 M to 1.2 M (+0.89 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 11,578 | 20,956 | 78,918 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 3,252 | 5,886 | 90,496 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 15,392 | 27,860 | 93,748 | |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.02 | 11,578 | 173,846 | 1,215,005 | 1.2 M to 1.2 M (-0.94 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 11,578 | 20,956 | 1,266,583 | 1.3 M to 1.3 M (+0.92 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 3,252 | 48,785 | 1,215,005 | 1.2 M to 1.2 M (-0.27 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 3,252 | 5,886 | 1,218,257 | 1.2 M to 1.2 M (+0.27 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 15,392 | 230,880 | 1,215,005 | 1.2 M to 1.2 M (-1.25 %) |
| Jun 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 15,392 | 27,860 | 1,230,397 | 1.2 M to 1.2 M (+1.27 %) |
| Jun 19 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | A | 14.43 | 270,000 | 3,896,100 | 270,000 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 1,100 | 1,991 | 109,140 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 4,203 | 7,607 | 110,240 | |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.08 | 1,100 | 16,583 | 1,215,005 | 1.2 M to 1.2 M (-0.09 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 1,100 | 1,991 | 1,216,105 | 1.2 M to 1.2 M (+0.09 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.00 | 4,203 | 63,045 | 1,215,005 | 1.2 M to 1.2 M (-0.34 %) |
| Jun 12 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 4,203 | 7,607 | 1,219,208 | 1.2 M to 1.2 M (+0.35 %) |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 3,650 | 6,607 | 114,443 | |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 15.02 | 3,650 | 54,829 | 1,215,005 | 1.2 M to 1.2 M (-0.30 %) |
| Jun 01 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 3,650 | 6,607 | 1,218,655 | 1.2 M to 1.2 M (+0.30 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 25,923 | 46,921 | 118,093 | |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 24,077 | 43,579 | 144,016 | |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.03 | 25,923 | 415,577 | 1,215,005 | 1.2 M to 1.2 M (-2.09 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 25,923 | 46,921 | 1,240,928 | 1.2 M to 1.2 M (+2.13 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.50 | 24,077 | 397,283 | 1,215,005 | 1.2 M to 1.2 M (-1.94 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 24,077 | 43,579 | 1,239,082 | 1.2 M to 1.2 M (+1.98 %) |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 616 | 1,115 | 168,093 | |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.92 | 616 | 10,426 | 1,215,005 | 1.2 M to 1.2 M (-0.05 %) |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 616 | 1,115 | 1,215,621 | 1.2 M to 1.2 M (+0.05 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 13,191 | 23,876 | 168,709 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 20,269 | 36,687 | 181,900 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 50,000 | 90,500 | 202,169 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.37 | 13,191 | 215,960 | 1,215,005 | 1.2 M to 1.2 M (-1.07 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 13,191 | 23,876 | 1,229,196 | 1.2 M to 1.2 M (+1.08 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.64 | 1,022 | 17,003 | 1,215,005 | 1.2 M to 1.2 M (-0.08 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.05 | 19,247 | 308,984 | 1,216,027 | 1.2 M to 1.2 M (-1.56 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 20,269 | 36,687 | 1,235,274 | 1.2 M to 1.2 M (+1.67 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.53 | 15,924 | 263,236 | 1,215,005 | 1.2 M to 1.2 M (-1.29 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 15,924 | 28,822 | 1,230,929 | 1.2 M to 1.2 M (+1.31 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 2,294 | 4,152 | 218,093 | |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 47,706 | 86,348 | 220,387 | |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 17.37 | 2,294 | 39,852 | 1,215,005 | 1.2 M to 1.2 M (-0.19 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 2,294 | 4,152 | 1,217,299 | 1.2 M to 1.2 M (+0.19 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 18.61 | 15,368 | 285,988 | 1,215,005 | 1.2 M to 1.2 M (-1.25 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 17.57 | 32,338 | 568,078 | 1,230,373 | 1.3 M to 1.2 M (-2.56 %) |
| Apr 21 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 47,706 | 86,348 | 1,262,711 | 1.2 M to 1.3 M (+3.93 %) |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | A | 14.00 | 200,000 | 2,800,000 | 200,000 |
Page: 1